Literature DB >> 15162332

Serum bile acids: reference values in healthy dogs and comparison of two kit methods.

L J Counsell1, J H Lumsden.   

Abstract

Serum bile acid (SBA) reference intervals were established by use of a radioimmunoassay method for fasting dogs to be 0.2 to 4.3 micro mol/L (n = 60) and for 2 hour postprandial samples to be 0.6 to 24.2 micro mol/L (n = 37). The SBA reference intervals estimated using an enzymatic method were 0 to 8.6 micro mol/L for fasting (n = 26) and 0 to 29.8 micro mol/L for 2 hour postprandial samples (n = 36). The correlation between the two methods including samples from healthy dogs and clinical cases is good (n = 128, r = 0.82, p < 0.0001). The radioimmunoassay method is linear to 50 micro mol/L and the enzymatic method is linear to 100 micro mol/L, thus both methods require serum dilutions to be made in many cases of primary liver disease. The enzymatic method is less expensive and more convenient for use in a clinical laboratory but requires a greater sample volume (400 micro I) than the RIA method (50 micro I). Both methods have adequate precision and accuracy to be useful as diagnostic tests of liver function in dogs.

Entities:  

Year:  1988        PMID: 15162332     DOI: 10.1111/j.1939-165x.1988.tb00494.x

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  3 in total

1.  Serum bile acids and the assessment of hepatic function in dogs and cats.

Authors:  D P Schlesinger; S I Rubin
Journal:  Can Vet J       Date:  1993-04       Impact factor: 1.008

2.  Reference intervals for preprandial and postprandial serum bile acid in adult rhesus macaques (Macaca mulatta).

Authors:  Marie-Josee M F Lemoy; Diccon R Westworth; Amir Ardeshir; Ross P Tarara
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-07       Impact factor: 1.232

3.  Analytical performance and method comparison of a quantitative point-of-care immunoassay for measurement of bile acids in cats and dogs.

Authors:  Kristina Weiler; Katharina Kleber; Sabine Zielinsky; Andreas Moritz; Natali Bauer
Journal:  J Vet Diagn Invest       Date:  2020-10-28       Impact factor: 1.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.